Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Bellile

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Head & Neck|April 13, 2022
Randomized trial of laryngeal organ preservation evaluating two cycles of induction chemotherapy with platinum, docetaxel, and a novel Bcl-xL inhibitorPaul L Swiecicki, Emily Bellile, Keith Casper, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 23, 2016
E6 and E7 Antibody Levels Are Potential Biomarkers of Recurrence in Patients with Advanced-Stage Human Papillomavirus-Positive Oropharyngeal Squamous Cell CarcinomaMatthew E Spector, Assuntina G Sacco, Emily Bellile, et al.
Annals of Surgical Oncology|December 22, 2017
Hypothyroidism and Wound Healing After Salvage LaryngectomyAndrew J Rosko, Andrew C Birkeland, Emily Bellile, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 22, 2024
Upfront Neck Dissection for Treatment Selection and Improvement in Quality of Life as a Novel Treatment Paradigm for Deintensification in HPV+ OPSCCPaul L Swiecicki, Emily Bellile, Aleksandar F Dragovic, et al.
Cancer Immunology, Immunotherapy : CII|October 27, 2018
Analysis of tumor-infiltrating CD103 resident memory T-cell content in recurrent laryngeal squamous cell carcinomaJacqueline E Mann, Joshua D Smith, Andrew C Birkeland, et al.
Head & Neck|February 19, 2019
Impact of American Joint Committee on Cancer Eighth Edition clinical stage and smoking history on oncologic outcomes in human papillomavirus-associated oropharyngeal squamous cell carcinomaPeter G Hawkins, Michelle L Mierzwa, Emily Bellile, et al.
Head & Neck|April 19, 2013
Weekly chemotherapy with radiation versus high-dose cisplatin with radiation as organ preservation for patients with HPV-positive and HPV-negative locally advanced squamous cell carcinoma of the oropharynxIrina Y Dobrosotskaya, Emily Bellile, Matthew E Spector, et al.
Investigational New Drugs|May 27, 2016
A phase II trial of the BCL-2 homolog domain 3 mimetic AT-101 in combination with docetaxel for recurrent, locally advanced, or metastatic head and neck cancerPaul L Swiecicki, Emily Bellile, Assuntina G Sacco, et al.
The Journal of Clinical Investigation|December 25, 2019
HPV16 drives cancer immune escape via NLRX1-mediated degradation of STINGXiaobo Luo, Christopher R Donnelly, Wang Gong, et al.
Head & Neck|September 26, 2017
Prognostic biomarkers in patients with human immunodeficiency virus-positive disease with head and neck squamous cell carcinomaHongzheng Zhang, Sungjin Kim, Zhengjia Chen, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Head & Neck|April 13, 2022
Randomized trial of laryngeal organ preservation evaluating two cycles of induction chemotherapy with platinum, docetaxel, and a novel Bcl-xL inhibitorPaul L Swiecicki, Emily Bellile, Keith Casper, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 23, 2016
E6 and E7 Antibody Levels Are Potential Biomarkers of Recurrence in Patients with Advanced-Stage Human Papillomavirus-Positive Oropharyngeal Squamous Cell CarcinomaMatthew E Spector, Assuntina G Sacco, Emily Bellile, et al.
Annals of Surgical Oncology|December 22, 2017
Hypothyroidism and Wound Healing After Salvage LaryngectomyAndrew J Rosko, Andrew C Birkeland, Emily Bellile, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 22, 2024
Upfront Neck Dissection for Treatment Selection and Improvement in Quality of Life as a Novel Treatment Paradigm for Deintensification in HPV+ OPSCCPaul L Swiecicki, Emily Bellile, Aleksandar F Dragovic, et al.
Cancer Immunology, Immunotherapy : CII|October 27, 2018
Analysis of tumor-infiltrating CD103 resident memory T-cell content in recurrent laryngeal squamous cell carcinomaJacqueline E Mann, Joshua D Smith, Andrew C Birkeland, et al.
Head & Neck|February 19, 2019
Impact of American Joint Committee on Cancer Eighth Edition clinical stage and smoking history on oncologic outcomes in human papillomavirus-associated oropharyngeal squamous cell carcinomaPeter G Hawkins, Michelle L Mierzwa, Emily Bellile, et al.
Head & Neck|April 19, 2013
Weekly chemotherapy with radiation versus high-dose cisplatin with radiation as organ preservation for patients with HPV-positive and HPV-negative locally advanced squamous cell carcinoma of the oropharynxIrina Y Dobrosotskaya, Emily Bellile, Matthew E Spector, et al.
Investigational New Drugs|May 27, 2016
A phase II trial of the BCL-2 homolog domain 3 mimetic AT-101 in combination with docetaxel for recurrent, locally advanced, or metastatic head and neck cancerPaul L Swiecicki, Emily Bellile, Assuntina G Sacco, et al.
The Journal of Clinical Investigation|December 25, 2019
HPV16 drives cancer immune escape via NLRX1-mediated degradation of STINGXiaobo Luo, Christopher R Donnelly, Wang Gong, et al.
Head & Neck|September 26, 2017
Prognostic biomarkers in patients with human immunodeficiency virus-positive disease with head and neck squamous cell carcinomaHongzheng Zhang, Sungjin Kim, Zhengjia Chen, et al.
Pageof 8